A myeloma cell line established from a patient refractory to thalidomide therapy revealed high-risk cytogenetic abnormalities and produced vascular endothelial growth factor
2007 ◽
Vol 27
(4)
◽
pp. 399-402
◽
2007 ◽
Vol 42
(12)
◽
pp. 1460-1465
◽
2004 ◽
Vol 64
(20)
◽
pp. 7500-7506
◽
2006 ◽
Vol 19
(9)
◽
pp. 978-978
◽
2003 ◽
Vol 121
(4)
◽
pp. 910-917
◽